| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | alfuzosin | FAERS: 3 | US FAERS | |
| 2 | Senna Extract | FAERS: 2 | US FAERS | |
| 3 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 4 | Bosentan | FAERS: 1 | US FAERS | |
| 5 | Erlotinib Hydrochloride | FAERS: 1 | US FAERS | |
| 6 | Liraglutide | FAERS: 1 | US FAERS | |
| 7 | Olmesartan Medoxomil | FAERS: 1 | US FAERS | |
| 8 | Somatuline Autogel | FAERS: 1 | US FAERS | |
| 9 | Temozolomide | FAERS: 1 | US FAERS | |
| 10 | alfuzosin | FAERS: 1 | US FAERS | |
| 11 | gemcitabine | FAERS: 1 | US FAERS | |
| 12 | rofecoxib | FAERS: 1 | OFFSIDES US FAERS | |
| 13 | Cisapride | OFFSIDES | ||
| 14 | Lidoderm | OFFSIDES | ||
| 15 | Methocarbamol | OFFSIDES | ||
| 16 | Triamcinolone Acetonide | OFFSIDES | ||
| 17 | ferrous gluconate | OFFSIDES | ||
| 18 | tizanidine | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120242
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.